Labmentor Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.86 M
- Revenue Growth 181.08%
- Profit Growth 262.63%
- Ebitda 332.42%
- Net Worth 195.72%
- Total Assets 217.90%
About Labmentor Biomedicals
Labmentor Biomedicals Private Limited (LBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 June 2021 (Three years and seven months 4 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.86 M.
Chintamani Mhaskar, Abhay Sahasrabudhe, Ravindra Chavan, and One other member serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190MH2021PTC362839
-
Company No.
362839
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jun 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Labmentor Biomedicals Private Limited offer?
Labmentor Biomedicals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Hematology Analyzers, Pathology Lab Equipments, Biochemistry Analyzer, IVDs & Analyzers, Analyzers & Analytical Instruments, High Pressure Liquid Chromatography System.
Who are the key members and board of directors at Labmentor Biomedicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintamani Mhaskar
|
Director | 28-Jun-2021 | Current |
|
Abhay Sahasrabudhe
|
Director | 28-Jun-2021 | Current |
|
Ravindra Chavan
|
Director | 28-Jun-2021 | Current |
|
Santosh Ingawale
|
Director | 24-Nov-2022 | Current |
Financial Performance of Labmentor Biomedicals.
Labmentor Biomedicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 181.08% increase. The company also saw a substantial improvement in profitability, with a 262.63% increase in profit. The company's net worth Soared by an impressive increase of 195.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labmentor Biomedicals?
In 2023, Labmentor Biomedicals had a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.86 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Aug 2024 | Others | ₹1.28 M | Open |
| 31 May 2024 | Others | ₹0.58 M | Open |
How Many Employees Work at Labmentor Biomedicals?
Unlock and access historical data on people associated with Labmentor Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labmentor Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labmentor Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.